It is very uncertain whether summary of findings: pioglitazone monotherapy changes all‐cause mortality (N) compared with no intervention (very low certainty).

1 finding from 1 review

Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk… 2020 · Cochrane Headline outcomes only
RR 0.85 [0.38, 1.91]
3 studies · 866 participants
Very low

Summary of findings: pioglitazone monotherapy vs no intervention

Incidence of T2DM (N) · people at increased risk for developing type 2 diabetes

Summary of findings: pioglitazone monotherapy probably leads to lower incidence of T2DM (N) Diagnostic criteria: 9 studies applied the WHO… compared with no intervention (moderate certainty).

1 finding from 1 review

Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk… 2020 · Cochrane Headline outcomes only
RR 0.31 [0.23, 0.4]
16 studies · 2053 participants
Moderate

Summary of findings: pioglitazone monotherapy vs no intervention

Serious adverse events (N) · people at increased risk for developing type 2 diabetes

Summary of findings: pioglitazone monotherapy showed no clear difference in serious adverse events (N) compared with no intervention (low certainty).

1 finding from 1 review

Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk… 2020 · Cochrane Headline outcomes only
RR 0.71 [0.38, 1.32]
7 studies · 1211 participants
Low

Summary of findings: pioglitazone monotherapy vs no intervention

Cardiovascular mortality · people at increased risk for developing type 2 diabetes

The review found no eligible studies for this question.

1 finding from 1 review

Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk… 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings: pioglitazone monotherapy vs no intervention

Non‐fatal myocardial infarction/stroke · people at increased risk for developing type 2 diabetes

The review found no eligible studies for this question.

1 finding from 1 review

Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk… 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings: pioglitazone monotherapy vs no intervention

Health‐related quality of life · people at increased risk for developing type 2 diabetes

The review found no eligible studies for this question.

1 finding from 1 review

Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk… 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings: pioglitazone monotherapy vs no intervention

Socioeconomic effects · people at increased risk for developing type 2 diabetes

The review found no eligible studies for this question.

1 finding from 1 review

Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk… 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings for education vs control

Falls · people with Parkinson's disease

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for preventing falls in Parkinson's disease 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings for education vs control

Number of people who experienced one or more falls · people with Parkinson's disease

It is very uncertain whether summary of findings for education changes number of people who experienced one or more falls compared with control (very low certainty).

1 finding from 1 review

Interventions for preventing falls in Parkinson's disease 2022 · Cochrane Headline outcomes only
Risk ratio 10.89 [1.26, 94.03]
1 study · 53 participants
Very low

Summary of findings for education vs control

Number of people sustaining one or more fall‐related fractures · people with Parkinson's disease

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for preventing falls in Parkinson's disease 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings for education vs control

Quality of life · people with Parkinson's disease

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for preventing falls in Parkinson's disease 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings for education vs control

Adverse events · people with Parkinson's disease

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for preventing falls in Parkinson's disease 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings for education vs control

Economic outcomes · people with Parkinson's disease

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for preventing falls in Parkinson's disease 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings: Conformal RT vs conventional dose RT

Mean GI symptom scores · People with urological (prostate) and gynaecological (cervical) cancer

1 finding from 1 review

Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic… 2018 · Cochrane Headline outcomes only
no estimate extracted
0 participants
GRADE not reported

Summary of findings: Conformal RT vs conventional dose RT

Acute and late GI toxicity (grade 2+) · People with urological (prostate) and gynaecological (cervical) cancer

1 finding from 1 review

Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic… 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 307 participants
High

Summary of findings: Conformal RT vs conventional dose RT

Diarrhoea (grade 2+) · People with urological (prostate) and gynaecological (cervical) cancer

1 finding from 1 review

Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic… 2018 · Cochrane Headline outcomes only
no estimate extracted
0 participants
GRADE not reported

Summary of findings: Conformal RT vs conventional dose RT

QoL · People with urological (prostate) and gynaecological (cervical) cancer

1 finding from 1 review

Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic… 2018 · Cochrane Headline outcomes only
no estimate extracted
0 participants
GRADE not reported